For Our Sponsors

Protenium Clinical Research, with 4 locations in the Dallas/Fort Worth Metroplex, is an independent, privately owned clinical research facility specializing in Phase I-IV clinical trials in a wide range of therapeutic areas. Although Protenium was established in January 2000, its founder, Dr. Robert Strzinek, has been involved in research for over thirty years.

Protenium Clinical Research has been the preferred choice of CRO’s and Pharmaceutical Sponsors to conduct clinical research because of its accuracy in reporting, attention to detail, aggressive recruitment and enrollment and, above all, its “patient first” approach to medicine.  Additionally, Protenium strives to work closely with study sponsors in a manner that is both stream-lined and responsive.

The staff of Protenium Clinical Research has healthcare roots based in the medical treatment and care of patients.  Our focus is on our interaction with the individuals who participate along with us in clinical research and, hopefully, touching their lives in a positive way.

ABOUT OUR RESEARCH FACILITY:

Protenium Clinical Research is centrally located in Hurst, Texas (a suburb of the Dallas/Fort Worth Metroplex), approximately 10 miles from Dallas/Fort Worth International Airport and 20 miles from Dallas Love Field Airport.

Protenium Clinical Research offers the following site features and capabilities:

CPR, ACLS certified personnel
Phlebotomy
Refrigerated centrifuge for lab specimen preparation
Emergency medication & crash cart
Automated External Defibrillator (AED)
24-Hour treatment and observation of patients
Dedicated drug storage area with locked keypad access
Dedicated rooms for subject evaluation
EKG equipment
-20 & -70 degree Fahrenheit freezers
24-hour temperature control and alarm system
911 Immediate Response
Fully equipped for gynecological evaluations
Full service hospital within 3 miles
Full radiology service within 2 blocks
Outpatient surgical center for EGD’s, colonoscopies, etc.
Monitor Workstation equipped with high-speed internet and access to both copier and fax machines
Conference Room

PROTENIUM IS PROUD TO HAVE PARTNERED WITH THE FOLLOWING COMPANIES:

AGI Therapeutics
Altana Pharma
AstraZeneca International
Bayer
BioSante Pharmaceutical, Inc.
Bristol-Myers Squibb
Covance
Cubist Pharmaceuticals
Daiichi Sankyo Company LTD
Diasome Pharmaceuticals
Elcelyx Therapeutics
Eli Lilly
Forest Research Institute
Furiex Pharmaceuticals
GlaxoSmithKline
Grunenthal
ISS
Johnson & Johnson
Mannkind Corp
Menarini Ricerche
Merck & Company
Meda Pharmaceuticals
MedPace, Inc.
Novartis Pharmaceuticals Corporation
Novo Nordisk, Inc.
Orexigen Therapeutics, Inc.
DepoMed, Inc.
Parexel International
Pfizer, Inc.
PPD, Inc.
PRA International
Proctor & Gamble
Progenics Pharmaceuticals
Purdue Pharma, LP
Quintiles
Replidyne, Inc.
Repros Therapeutics
Sanofi Aventis
Sanofi Pasteur
Schwarz Pharma
Shionogi Inc.
Solvay
Sucampo Pharmaceuticals
Takeda Global Research Center
Tethys Bioscience
Theravance, Inc.
Tolerx
Wyeth

PROTENIUM HAS EXPERIENCE IN THE FOLLOWING THERAPEUTIC AREAS:

Alzheimer’s Disease
Artheosclerotic Heart Disease
Anxiety Disorders
Atopic Dermatitis
Bronchitis
Chronic Obstructive Lung Disease
Constipation
Contact Dermatitis
Contraception
Diabetes Mellitus – Type I & Type II
Dyspepsia
Female Sexual Dysfunction
Gastroenteritis
GERD
Hormone Replacement Therapy
Hypertension
Hypogonadism
Irritable Bowel Syndrome
Lipid Disorders
Menopause
Migraine Headaches
Mood Disorders
Obesity
Opioid Induced Constipation
Osteoarthritis
Otitis Media
Overactive Bladder
Pain Syndromes
Peripheral Vascular Disease
Pharyngitis
Pneumonia
Postmenapausal Syndrome
Prostatic Disorders
Psoriasis
Respiratory Tract Infection
Rheumatoid Arthritis
Rhinitis
Sexual Disorders
Sinusitis
Sleep Disorders
Stroke Prevention
Stroke Rehabilitation
Tonsilitis
Vaginitis